| USP | Ubiquitin-specific protease |
| DUB | Deubiquitinating enzyme |
| PTM | Post-translational modification |
| CKD | Chronic kidney disease |
| HGNC | Human Genome Nomenclature Committee |
| UBP | Ubiquitin-Specific Processing Protease |
| UBD | Ubiquitin-binding domain |
| ZnF-UBP | Zinc-finger ubiquitin binding protein |
| DUSP | USP-specific protease domains |
| UBL | Ubiquitin-like domains |
| DNMT1 | DNA methyltransferase 1 |
| WDR | WD40-repeats |
| LAP | Latent-related peptide |
| LTBP | latent TGF-β-binding protein |
| TGF-β1 | Transforming Growth Factor- β 1 |
| ECM | extracellular matrix |
| TβRI | TGF-β type I receptor |
| TβRII | TGF-β type II receptor |
| STRAP | Serine-Threonine Kinase Receptor-Associated Protein |
| GEF | Guanine nucleotide exchange factor |
| EMT | Epithelial-to-mesenchymal transition |
| TCF4 | Transcription factor T cell factor 4 |
| TRAF6 | Tumor necrosis factor receptor-related factor 6 |
| UBI2 | Unique ubiquitin-like domain 2 |
| IκBα | NF-κB inhibitor protein |
| Ang II | Angiotensin II |
| NLRP3 | NOD-, LRR- and pyrin domain-containing protein 3 |
| ROS | Reactive oxygen species |
| SOD2 | Superoxide Dismutase 2 |
| ACSL4 | Long-chain acyl-CoA synthase |
| UBI2 | Ubiquitin-like domain 2 |
| PDK1 | Pyruvate dehydrogenase kinase 1 |
| FN | Fibronectin |
| α-SMA | α-smooth muscle actin |
| AGEs | Advanced glycation end products |
| FGF2 | Fibroblast growth factor 2 |
| IRI | Ischemia–reperfusion injury |
| RTECs | Renal tubular epithelial cells |
| HIF-1α | Hypoxia-Inducible Factor 1-α |
| EGFR | Epidermal Growth Factor Receptor |
| SASP | Senescence-Associated Secretory Phenotype |
| Tfap2α | Transcription factor AP-2α |
| TBK1 | TANK-binding kinase 1 |
| KLF4 | Krüppel-like factor 4 |
| DKD | Diabetic nephropathy |
| UUO | Unilateral ureteral obstruction |
| PROTACs | Proteolysis Targeting Chimeras |
| TXNDC5 | thioredoxin domain containing 5 |